Pregnancy, ovulation and drug testing test products

 Quality Medical & Forensic
Diagnostics Since 1984 ...

...Wholesale Direct Prices on Home Health Diagnostic Test Kits... Alcohol and Drug of Abuse Screening, Pregnancy and Fertility Testing, General Health Diagnostics... Low Cost, Fast, Accurate and Confidential Diagnostic Health Solutions...













BorderHorztshdowlfta.gif (1010 bytes)

HACKER SAFE certified sites prevent over 99.9% of hacker crime.

 


Using the QuickScreen™ Pro Drug Scan Test

Drug testing device(8566 bytes)

MATERIAL REQUIRED FOR ASSAY

point12.gif (472 bytes) Adequate clean specimen collection container.
point12.gif (472 bytes) QuickScreen™ Pro Multi-Drug Test Card
point12.gif (472 bytes) Uncontaminated, fresh urine Sample

TIMING DEVICE

Timerani

The QuickScreen Pro Multi-Drug Test Card now incorporates an automatic timing device. The timer has two indicator "lights" that will turn a red color tone as critical periods are reached during the development of test panel results. A "result ready" indicator will show when test results are completely developed and ready to be interpreted, while a "result expired" indicator will show when test development time is beyond that specified for a correct interpretation of test results. This new timing device eliminates the need for a separate timer during testing and potential interpretation errors due to improper waiting periods.

SPECIMEN COLLECTION

The QuickScreen Pro Multi-Drug Test Card is formulated for use with human urine specimens only. Fresh urine does not require any special handling or pretreatment. Urine samples should be collected such that testing may be performed as soon as possible after the specimen collection, preferably during the same day. The specimen may be refrigerated at 2-8° C for 2 days or frozen at -20° C for a longer period of time. Specimens that have been refrigerated must be equilibrated to room temperature prior to testing. Specimens previously frozen must be thawed, equilibrated to room temperature, and mixed thoroughly prior to testing.

PRECAUTIONS

Urine specimens may be potentially infectious. Proper handling and disposal methods should be established. Avoid cross-contamination of urine samples by using a new specimen collection container for each urine sample.
Note: Urine specimens, and all materials coming in contact with them, should be handled and disposed as if capable of transmitting infection. Avoid contact with skin by wearing gloves and proper attire.

TEST PROCEDURE

D_inusesml1.gif (7928 bytes)

Review "Specimen Collection" instructions. Test device, patient's sample, and controls should be brought to room temperature (20-30° C) prior to testing
  Do not open pouch until ready to perform the assay.
Remove the test device from the protective foil pouch (bring the device to room temperature before opening the pouch to avoid condensation of moisture on the membrane).
Label the device with patient or control number identification.
Immerse the sample absorbent pads in urine for about 10 seconds or until visible migration of the sample across the test panels has started. Then place the device on a flat surface. Another option is to simply leave the card immersed in the sample. 
  Do not allow urine to exceed the the "Max Line" of the test.
Read the results when the "results ready" indicator changes a pinkish red color
  Do not read results after 15 minutes or when the "results expired" indicator changes color.

Druginuselabeled2.jpg (9229 bytes)

INTERPRETATION OF RESULTS

(-) Negative: Two colored lines adjacent to each drug name should be observed in the viewing window. The line in the test region (T) is the drug probe line; the line in the control region (C) is the control line, which is used to indicate proper performance of the device. The test line intensity may be weaker or stronger than that of the control line.
(+) Positive: Only one colored line appears in the control region (C). The absence of a test line indicates a positive result for that drug.
(-/+) Inconclusive: A faint*, indistinguishable line appears in the test region (T) . While probably suggesting a negative result, the test is inconclusive and suggests that the drug in the panel could be near the cut-off concentration level for detection. Perform a second test or take the sample for more extensive laboratory testing. Because of the quality controls built into the test device, an inconclusive result is highly unlikely.
Invalid: No line appears in the control region. Under no circumstances should a positive sample be identified until the control (C) line forms in the viewing area. If the control line (C) does not form, the test result is invalid and the assay should be repeated.

View Result Graphic

Drug Testing Results(12074 bytes)

5panelresultani.gif (7694 bytes)

*Note: An extremely faint line (barely visible) in the test region indicates that a drug metabolite in the sample may near the cut-off concentration  level for the test. Normally, any line in the test area should be interpreted as a negative test. If suspicion or uncertainty remains regarding the test results, there are several options available: The donor can be retested at another time with a new test card and sample, the same sample can be retested using a new test card, or the sample can be evaluated by a testing laboratory. If laboratory confirmation is desired or indicated, please see the QuickScreen Pro Drug Test Kit

LIMITATIONS OF TEST PROCEDURE

  • This assay is designed for use with human urine only.

  • A positive result with any of the tests indicates only the presence of a drug/metabolite and does not indicate or measure the level of intoxication.

  • There is a possibility that technical or procedural errors as well other substances as factors not listed may interfere with the test and cause false results. Included with each card are lists of substances that could produce positive results, or that are known not to interfere with test performance.

  • If it is suspected that the samples have been mislabeled or tampered with, a new specimen should be collected and the test repeated or an Adulteration ID Test should be obtained.

For details on the chemistry technology of the test please refer to test technology or the Drug FAQ page.

 

BorderHorztshdowlfta.gif (1664 bytes)

HACKER SAFE certified sites prevent over 99.9% of hacker crime.

Copyright ©1997-2012
all rights reserved